News & Updates

Original New Drug Application Approvals by US FDA (16-28 February 2025)

14 Mar 2025

New drug applications approved by US FDA as of 16-28 February 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-28 February 2025)

14 Mar 2025

SG sees drop in paediatric pneumococcal disease burden

13 Mar 2025 by

The introduction of pneumococcal conjugate vaccines (PCV) into Singapore's National Childhood Immunisation Schedule (NCIS) has reduced the incidence of invasive pneumococcal disease (IPD) in children by nearly a third, as reported in a study.

SG sees drop in paediatric pneumococcal disease burden

13 Mar 2025

Young adults unaware of male HPV infection, vaccine benefits

13 Mar 2025 by

Awareness about human papillomavirus (HPV) infection in males and the benefits of vaccination on both genders is low among young adults, reveals a Singapore study.

Young adults unaware of male HPV infection, vaccine benefits

13 Mar 2025

COVID-19 may leave lingering GI issues in children

10 Mar 2025 by

In children and adolescents who have contracted COVID-19, gastrointestinal (GI) tract symptoms may remain for up to 2 years, as reported in a large retrospective study.

COVID-19 may leave lingering GI issues in children

10 Mar 2025

Children with post-COVID syndrome carry socio-educational burden

10 Mar 2025 by

Paediatric post-COVID syndrome (pPCS) brings a substantial socio-educational burden that must be included in medical, social, and educational care, suggests a study.

Children with post-COVID syndrome carry socio-educational burden

10 Mar 2025

Original New Drug Application Approvals by US FDA (1-15 February 2025)

10 Mar 2025

New drug applications approved by US FDA as of 1-15 February 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (1-15 February 2025)

10 Mar 2025

Tetracycline trumps macrolide in MRMP pneumonia

09 Mar 2025

Tetracycline demonstrates superior clinical efficacy to that of macrolide in children with macrolide-resistant Mycoplasma pneumoniae (MRMP) pneumonia, a study has shown.

Tetracycline trumps macrolide in MRMP pneumonia

09 Mar 2025

Ivermectin falls flat against mild-to-moderate COVID-19

08 Mar 2025

Treatment with ivermectin for mild-to-moderate COVID-19 does not appear to reduce recovery time as compared with placebo, according to data from the ongoing ACTIV-6* study.

Ivermectin falls flat against mild-to-moderate COVID-19

08 Mar 2025

High-dose sulbactam tied to greater Cmid, PK-PD achievement

07 Mar 2025

Treatment with high-dose sulbactam leads to higher mid-dosing (Cmid) and pharmacokinetic-pharmacodynamic (PK-PD) achievement in paediatric patients, reports a study.

High-dose sulbactam tied to greater Cmid, PK-PD achievement

07 Mar 2025

COVID-19 ups AIBD risk, but vaccination helps

06 Mar 2025 by

Individuals with COVID-19 infection are at higher risk of autoimmune blistering disease (AIBD), but vaccination helps reduce such risk, suggests a study.

COVID-19 ups AIBD risk, but vaccination helps

06 Mar 2025

News & Updates

Filter by Specialty:

Specialty:

Original New Drug Application Approvals by US FDA (16-28 February 2025)

Original New Drug Application Approvals by US FDA (16-28 February 2025)

SG sees drop in paediatric pneumococcal disease burden

SG sees drop in paediatric pneumococcal disease burden

Young adults unaware of male HPV infection, vaccine benefits

Young adults unaware of male HPV infection, vaccine benefits

COVID-19 may leave lingering GI issues in children

COVID-19 may leave lingering GI issues in children

Children with post-COVID syndrome carry socio-educational burden

Children with post-COVID syndrome carry socio-educational burden

Original New Drug Application Approvals by US FDA (1-15 February 2025)

Original New Drug Application Approvals by US FDA (1-15 February 2025)

Tetracycline trumps macrolide in MRMP pneumonia

Tetracycline trumps macrolide in MRMP pneumonia

Ivermectin falls flat against mild-to-moderate COVID-19

Ivermectin falls flat against mild-to-moderate COVID-19

High-dose sulbactam tied to greater Cmid, PK-PD achievement

High-dose sulbactam tied to greater Cmid, PK-PD achievement

COVID-19 ups AIBD risk, but vaccination helps

COVID-19 ups AIBD risk, but vaccination helps